scispace - formally typeset
Search or ask a question

How to combine microfluidic chip with biosensor? 


Best insight from top research papers

Microfluidic chips can be combined with biosensors by integrating a microelectrode and a cathodic photoelectrochemical (PEC) biosensor on the chip . This integration allows for the ultrasensitive detection of specific biomarkers, such as non-small cell lung cancer cytokeratin fragments. The microfluidic chip utilizes a signal amplification strategy based on the p-n junction of AgI/Bi2Ga4O9 and a superoxide-dismutase-loaded honeycomb manganese oxide nanostructure (SOD@hMnO2) as the co-catalyst signal amplification label. This amplification strategy enhances the cathodic PEC behavior, resulting in excellent linearity and a low detection limit for the targeted detection objects . Additionally, microfluidic chips can be combined with surface-enhanced Raman scattering (SERS) substrates to create biosensor chips with various indicator selection functions . The biosensor chip consists of an upper module and a lower module, which includes a microfluidic device and a SERS substrate. This combination enables the diagnosis of various cancers by collecting light reflected after irradiating a laser to a test sample . Microfluidic-chip integrated optical biosensors have also been developed for simultaneous detection of multiple analytes. The microfluidic chip provides an ideal platform for the integration of high-throughput biosensors, allowing for the analysis of multiple analytes in a single device . Furthermore, microfluidics can be integrated with solid-state nanopores to create stand-alone devices for nucleic acid and protein characterization. The microfluidic device combines a bioassay reaction/purification chamber with a solid-state nanopore sensor, allowing for sample preparation, purification, and electrical readout detection in a single device .

Answers from top 4 papers

More filters
Papers (4)Insight
The paper describes the combination of a microfluidic chip with a biosensor by using micro-machining and heat bonding techniques to form the chip.
The paper discusses the integration of microfluidics in biosensor technology, offering new opportunities for future biosensing applications. It describes the fabrication and designing of microfluidics platform technology for biosensors.
The paper provides a comprehensive review of the recent advances in combining microfluidic chips with optical biosensors for simultaneous detection of multiple analytes.
The paper describes the design of a microfluidic chip integrated with a cathodic photoelectrochemical (PEC) biosensor for the ultrasensitive detection of cytokeratin fragments. It explains the mechanism for signal amplification using a p-n junction and a co-catalyst signal amplification label. However, it does not specifically mention how the microfluidic chip is combined with the biosensor.

Related Questions

How Microfluidic approaches in lung cancer detection?5 answersMicrofluidic approaches play a crucial role in lung cancer detection by offering high-throughput and sensitive methods for analyzing circulating tumor DNA (ctDNA). Surface-enhanced Raman spectroscopy (SERS) integrated with signal amplification strategies in a microfluidic chip enables the detection of prognostic ctDNAs with high sensitivity. Additionally, a microfluidic chip system utilizing specific tumor biomarkers like hexaminolevulinate (HAL) has shown promise in concentrating and identifying tumor cells in pleural effusion, aiding in clinical detection. Furthermore, a novel microsensor technology, Electric-Field-Induced Released and Measurement (EFIRM) Liquid Biopsy, offers a non-PCR and non-NGS-based multiplex platform for detecting lung cancer-associated ultra-short ctDNA with high accuracy. These advancements highlight the potential of microfluidic approaches in enhancing the efficacy of lung cancer diagnosis and prognosis.
What are the advantages of microfluidics?4 answersMicrofluidics offers several advantages in various fields of biotechnology. These include reduced chemical and sample consumption, increased energy and mass transfer, and smaller device size. In the context of assisted reproduction, microfluidics enables the selection of high-quality motile sperm cells with non-damaged DNA, leading to greater success in insemination and enhanced pregnancy rates. In biochemical operations, microfluidic devices provide smaller tool size, lower reagent use, faster response kinetics, increased parallelism, and automation, resulting in lower test costs and faster operation. Microfluidic devices also offer high heat and mass transfer, good process control, and reduced energy consumption and waste generation in separation and purification techniques. Additionally, microfluidics allows for precise control of hydrodynamic and physicochemical microenvironments, facilitating the study of biofilms and advancements in infection models and characterization methods.
What are the amounts of antibody and wash used in microfluidic lab on chip devices for assays?5 answersMicrofluidic lab-on-chip devices for assays use varying amounts of antibody and wash solutions. In one study, a high-throughput microfluidic platform was capable of quantitating up to 384 biomarkers using pairs of capture and detection antibodies, but the specific amounts of antibody and wash used were not mentioned. Another study mentioned the advantages of microfluidic technology, including the use of only a fraction of the staining reagents generally needed for flow cytometry and only 30,000 cells per sample, but did not provide specific amounts of antibody and wash. A cost-effective lab-on-a-disc design for simultaneous detection of multiple protein biomarkers mentioned a significant reduction in the amount of washing buffer used, but did not specify the exact amounts of antibody and wash. A pneumatically gated microfluidic communicating vessel chip was developed for immunomagnetic ELISA, but the amounts of antibody and wash used were not mentioned. Therefore, the specific amounts of antibody and wash used in microfluidic lab-on-chip devices for assays are not provided in the abstracts.
How much antibody is needed for elisa for a microfluidic lab on chip device?5 answersThe amount of antibody needed for ELISA in a microfluidic lab-on-a-chip device varies depending on the specific design and assay requirements. In one study, the ELISA-on-a-chip utilized 70 µL of detection antibody. Another study reported a limit of detection of 20 pM for rabbit IgG antibody detection using an autonomous ELISA on a microfluidic paper-based analytical device (µPAD). In a thermoelectric ELISA method, the concentration of the analyte was determined by detecting the heat of the enzymatic reaction between glucose oxidase conjugated to an IgG detection antibody and glucose. Additionally, a miniature 96 sample ELISA-lab-on-a-chip used a simple microfluidics system and detected Staphylococcal Enterotoxin B (SEB) at concentrations as low as 0.1 ng ml(-1). Therefore, the amount of antibody needed for ELISA in a microfluidic lab-on-a-chip device can vary depending on the specific assay and detection requirements, and the design of the device.
How can biomimetic integration techniques be used to improve the performance of microfluidic systems?5 answersBiomimetic integration techniques can be used to improve the performance of microfluidic systems. By using bio-inspired structural and functional designs, biomimetic microfluidic systems can overcome the limitations of current devices, such as anti-fouling, smart, and dynamic response inside the microchannels under different environments. These systems can incorporate biomimetic features like self-diagnosis and self-repair capabilities, extending their useful lifetime. Through multidisciplinary approaches, bio-inspired microfluidics can create biomimetic microenvironments that mimic the physiological features of organs, enabling the construction of high-fidelity human organ structures in vitro. By integrating biomimetic functions, such as chemotaxis and precision control of flow behavior, microfluidic systems can achieve performance characteristics beyond current devices. These advancements in biomimetic microfluidics offer new ideas for the design and application of smart microfluidics, contributing to the development of soft matter, multi-functional, and smart biomimetic devices.
How can microfluidic sensors be used to determine the concentration of metabolites?3 answersMicrofluidic sensors can be used to determine the concentration of metabolites through various methods. One approach is using electrophoresis, where an electric field is applied across a microfluidic channel to drive charged particles towards or away from electrodes. Another method involves using optical sensors with fiber tips integrated into the microfluidic chip, allowing real-time monitoring of concentration and temperature. Additionally, a microfluidic sensor based on an array of hydrogel-entrapped enzymes can simultaneously detect different concentrations of the same analyte or multiple analytes in real time. These sensors are easy to fabricate and eliminate the possibility of cross talk between enzymes. Furthermore, bioanalytical microfluidic sensors offer the advantages of microsystems, allowing for on-line measurement, bioassays, and quasi-continuous assays like immunoassays. Overall, microfluidic sensors provide a versatile and efficient platform for determining the concentration of metabolites.

See what other people are reading

What is the history and development of microfluidic devices like Comsol micromixers?
5 answers
How to sort methylation data regarding SNPs and MAF?
5 answers
What is the prevalence and clinical manifestation of Feline Polyomavirus (FPyV) in domestic cats?
5 answers
What is the prevalence and clinical manifestation of Feline Polyomavirus (FPyV) in domestic cats?
5 answers
What are the technical limitations of using SARS-CoV-2 Quantitative PCR (qPCR) analysis?
4 answers
Using SARS-CoV-2 Quantitative PCR (qPCR) analysis presents several technical limitations. Firstly, the analysis of viral RNA levels with singly-imputed values can lead to biased treatment effect estimates, highlighting pitfalls in imputation methods. Secondly, while saliva-based nucleic acid detection is a convenient alternative to nasopharyngeal swabs, the impact of saliva on viral RNA detection remains poorly understood, potentially affecting the sensitivity of the analysis. Additionally, the performance of diagnostic tests can vary, with differences in sensitivity observed between commercial RT-qPCR kits, emphasizing the importance of evaluating kit performance to avoid false negatives and local outbreaks. Lastly, challenges in detecting SARS-CoV-2 bioaerosols in urban ambient air due to low viral loads necessitate highly specific bioanalysis platforms for accurate identification and quantitation.
Why are biomarkers good for disease diagnosis?
5 answers
Biomarkers are crucial for disease diagnosis due to their ability to provide measurable indicators of normal or abnormal biological processes, aiding in the identification of diseases and monitoring treatment responses. They offer a means to objectively quantify an organism's exposure to various procedures or responses to drug interventions, facilitating efficient diagnosis and treatment selection in the presence of multiple options. Biomarkers, including nucleic acids and proteins, play a significant role in early disease detection and monitoring treatment effects, especially in resource-limited settings. The integration of advanced technologies like LC-MS and NMR allows for the identification and characterization of biomarkers, enabling the early detection of diseases and personalized treatment approaches. In infectious diseases, biomarkers aid in distinguishing between bacterial and viral infections, guiding appropriate treatment decisions and improving patient management.
How important are biomarkers in disease diagnosis?
5 answers
Biomarkers play a crucial role in disease diagnosis by providing measurable indicators of normal or abnormal biological processes, aiding in distinguishing between bacterial and viral infections, and enabling early detection and prognosis of diseases. Advanced technologies like LC-MS and NMR are instrumental in biomarker discovery, allowing for the identification of early biochemical changes in diseases and facilitating personalized treatment approaches. The use of biomarkers, including nucleic acid and protein biomarkers, is essential for early disease diagnosis and monitoring treatment effects, especially in resource-limited settings. Overall, biomarkers are vital tools that enhance diagnostic accuracy, guide treatment decisions, and contribute to the development of targeted therapies, ultimately improving patient outcomes.
How can the analyte transport dimensionality be reduced for faster analyte capture?
5 answers
To reduce analyte transport dimensionality for faster capture, various techniques can be employed. One approach involves utilizing dielectrophoresis to manipulate single-particle passage through solid-state pores, enabling control over particle flows in transverse directions. Another method is the integration of a microarray with an ion concentration polarization (ICP) based microfluidic concentrator, which enhances hybridization speed by preconcentrating target biomolecules into a small volume near the probes, reducing diffusion length and increasing binding reaction rates. Additionally, employing dimensionality reduction techniques like linear discriminant analysis can compress multidimensional leakage into a single sample, aiding in computational complexity reduction while maintaining attack optimality. These strategies collectively contribute to faster analyte capture by simplifying transport dynamics and enhancing capture efficiency.
How can the analyte transport dimensionality be reduced for faster analyte capture? Using confocal microscopy?
5 answers
To reduce analyte transport dimensionality for faster capture, various methods can be employed based on the research contexts provided. One approach involves integrating a microarray with an ion concentration polarization (ICP) concentrator to enhance hybridization speed by reducing analyte diffusion length. Another method utilizes dielectrophoresis to manipulate single-particle passage through a solid-state pore, controlling particle flows and enhancing capture efficiency. Additionally, in the study of optical affinity biosensors, changes in nanoplasmonic architecture can affect analyte transport rates, with complex structures impacting sensing performance significantly. Confocal microscopy can be utilized to observe and analyze these processes, providing insights into the mechanisms of analyte transport and capture efficiency in various systems.
What is the purpose of quantifying gfp in qPCR analysis of a DNA sample?
5 answers
Quantifying GFP (Green Fluorescent Protein) in qPCR analysis of a DNA sample serves various purposes. Firstly, qPCR with fluorescent probes enhances specificity and sensitivity in detecting DNA molecules, making it valuable for gene expression analysis, mutation detection, genotyping, and DNA quantification. Secondly, standard curves in qPCR assays aid in calculating the initial amount of target DNA, crucial for accurate quantification in genetic disorder screening. Additionally, digital PCR (dPCR) has emerged as an alternative method for GMO quantification, showing accurate and precise results without the need for standard curves, making it suitable for routine GMO testing. Therefore, quantifying GFP in qPCR analysis not only enables precise quantification of DNA but also ensures specificity and accuracy in various applications, ranging from genetic disorder screening to GMO quantification.
Has MAP protein multiplexing been used in FFPE samples?
4 answers
Yes, multiplex protein profiling in FFPE samples has been achieved using various technologies like ChipCytometry, Digital Spatial Profiling (DSP), and InSituPlex® method. ChipCytometry enables the simultaneous detection of multiple protein biomarkers in FFPE tissues while preserving spatial context. DSP allows for highly multiplexed spatial profiling of proteins in FFPE samples, offering single-cell sensitivity and the potential to profile up to 44 proteins. Additionally, the InSituPlex® method demonstrates the spatial profiling of immune markers in FFPE tumor tissues, showcasing the benefits of fast staining workflows and compatibility with existing instrumentation. These technologies collectively showcase the feasibility and advancements in multiplex protein profiling in FFPE samples for in-depth analysis of cellular phenotypes and tumor microenvironments.